サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/05/07 | 3,035 | 3,035 | 2,955 | 3,010 | ±0 | ±0% | 112,200 |
| 2018/05/02 | 3,015 | 3,040 | 2,954 | 3,010 | +10 | +0.3% | 164,400 |
| 2018/05/01 | 3,040 | 3,070 | 2,996 | 3,000 | -40 | -1.3% | 179,100 |
| 2018/04/27 | 2,930 | 3,080 | 2,926 | 3,040 | +126 | +4.3% | 282,000 |
| 2018/04/26 | 2,988 | 2,988 | 2,900 | 2,914 | -35 | -1.2% | 235,300 |
| 2018/04/25 | 2,931 | 2,968 | 2,910 | 2,949 | +41 | +1.4% | 138,100 |
| 2018/04/24 | 2,997 | 3,010 | 2,902 | 2,908 | -60 | -2% | 202,200 |
| 2018/04/23 | 2,869 | 2,972 | 2,837 | 2,968 | +49 | +1.7% | 232,100 |
| 2018/04/20 | 2,820 | 2,979 | 2,811 | 2,919 | +51 | +1.8% | 476,200 |
| 2018/04/19 | 3,050 | 3,050 | 2,867 | 2,868 | -177 | -5.8% | 689,400 |
| 2018/04/18 | 3,020 | 3,090 | 2,989 | 3,045 | -15 | -0.5% | 290,200 |
| 2018/04/17 | 3,135 | 3,180 | 2,891 | 3,060 | -130 | -4.1% | 687,700 |
| 2018/04/16 | 3,200 | 3,240 | 3,120 | 3,190 | +30 | +0.9% | 280,600 |
| 2018/04/13 | 3,225 | 3,250 | 3,155 | 3,160 | -65 | -2% | 225,400 |
| 2018/04/12 | 3,180 | 3,295 | 3,155 | 3,225 | +20 | +0.6% | 322,500 |
| 2018/04/11 | 3,315 | 3,320 | 3,110 | 3,205 | -110 | -3.3% | 377,800 |
| 2018/04/10 | 3,315 | 3,420 | 3,270 | 3,315 | -20 | -0.6% | 329,500 |
| 2018/04/09 | 3,265 | 3,395 | 3,230 | 3,335 | +70 | +2.1% | 260,900 |
| 2018/04/06 | 3,390 | 3,420 | 3,250 | 3,265 | -155 | -4.5% | 400,700 |
| 2018/04/05 | 3,395 | 3,445 | 3,345 | 3,420 | +80 | +2.4% | 235,700 |
| 2018/04/04 | 3,420 | 3,450 | 3,280 | 3,340 | -55 | -1.6% | 256,000 |
| 2018/04/03 | 3,330 | 3,440 | 3,325 | 3,395 | -40 | -1.2% | 293,700 |
| 2018/04/02 | 3,565 | 3,655 | 3,435 | 3,435 | -120 | -3.4% | 619,300 |
| 2018/03/30 | 3,350 | 3,575 | 3,335 | 3,555 | +240 | +7.2% | 561,900 |
| 2018/03/29 | 3,230 | 3,385 | 3,185 | 3,315 | +100 | +3.1% | 355,700 |
| 2018/03/28 | 3,200 | 3,280 | 3,165 | 3,215 | +10 | +0.3% | 347,600 |
| 2018/03/27 | 3,335 | 3,450 | 3,200 | 3,205 | -115 | -3.5% | 681,200 |
| 2018/03/26 | 3,670 | 3,670 | 3,285 | 3,320 | -365 | -9.9% | 786,500 |
| 2018/03/23 | 3,555 | 3,715 | 3,535 | 3,685 | -30 | -0.8% | 539,100 |
| 2018/03/22 | 3,500 | 3,745 | 3,465 | 3,715 | -85 | -2.2% | 855,400 |
| 2018/03/20 | 3,795 | 3,860 | 3,750 | 3,800 | -70 | -1.8% | 308,900 |
| 2018/03/19 | 3,955 | 3,965 | 3,790 | 3,870 | -125 | -3.1% | 374,600 |
| 2018/03/16 | 4,225 | 4,290 | 3,835 | 3,995 | -255 | -6% | 681,700 |
| 2018/03/15 | 4,410 | 4,455 | 4,190 | 4,250 | -90 | -2.1% | 624,000 |
| 2018/03/14 | 4,135 | 4,460 | 4,125 | 4,340 | +240 | +5.9% | 1,544,500 |
| 2018/03/13 | 3,980 | 4,120 | 3,930 | 4,100 | +90 | +2.2% | 422,700 |
| 2018/03/12 | 3,925 | 4,020 | 3,895 | 4,010 | +125 | +3.2% | 410,500 |
| 2018/03/09 | 3,970 | 3,980 | 3,825 | 3,885 | +50 | +1.3% | 353,400 |
| 2018/03/08 | 3,860 | 3,890 | 3,775 | 3,835 | +40 | +1.1% | 234,400 |
| 2018/03/07 | 3,715 | 3,850 | 3,625 | 3,795 | +110 | +3% | 332,800 |
| 2018/03/06 | 3,680 | 3,725 | 3,625 | 3,685 | +180 | +5.1% | 328,800 |
| 2018/03/05 | 3,780 | 3,835 | 3,430 | 3,505 | -300 | -7.9% | 579,600 |
| 2018/03/02 | 3,785 | 3,850 | 3,750 | 3,805 | -85 | -2.2% | 260,200 |
| 2018/03/01 | 3,820 | 3,920 | 3,770 | 3,890 | ±0 | ±0% | 382,000 |
| 2018/02/28 | 3,895 | 3,985 | 3,890 | 3,890 | -40 | -1% | 339,600 |
| 2018/02/27 | 4,000 | 4,030 | 3,905 | 3,930 | +30 | +0.8% | 374,600 |
| 2018/02/26 | 3,995 | 4,135 | 3,880 | 3,900 | +170 | +4.6% | 1,201,700 |
| 2018/02/23 | 3,695 | 3,770 | 3,660 | 3,730 | +80 | +2.2% | 355,400 |
| 2018/02/22 | 3,700 | 3,760 | 3,570 | 3,650 | -60 | -1.6% | 374,400 |
| 2018/02/21 | 3,690 | 3,815 | 3,645 | 3,710 | -20 | -0.5% | 567,300 |
1751～
1800
件表示中 / 2503件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 217,100円 | - | - | 0.00% | - | 100.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 379,000円 | -6.4% | -71.8% | 5.01% | 42.33倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.05倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 293,400円 | +7.9% | -3.3% | 2.73% | 8.16倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 204,200円 | +3.1% | -6.5% | 2.35% | 9.47倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
